JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Delgado-Bolton, R. C.
Right arrow Articles by Carreras, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Delgado-Bolton, R. C.
Right arrow Articles by Carreras, J. L.

Meta-Analysis of the Performance of 18F-FDG PET in Primary Tumor Detection in Unknown Primary Tumors

Roberto C. Delgado-Bolton, MD1, Cristina Fernández-Pérez, MD2, Alfredo González-Maté, MD1 and José L. Carreras, MD, PhD1

1 Department of Nuclear Medicine, Hospital Clínico San Carlos, Madrid, Spain
2 Research Unit, Hospital Clínico San Carlos, Madrid, Spain



View larger version (34K):

[in a new window]
 
FIGURE 1. Histopathology of metastasis from UPT as described by Daugaard (2) compared with meta-analysis pooled-data and restricted data. Meta-analysis restricted data excluded studies that only included patients with cervical lymphadenopathies (11,34,35) and patients with cervical lymphadenopathies of squamous cell carcinoma (13–15). Squamous cell Ca. = squamous cell carcinoma; Adenoca. = adenocarcinoma; Undifferentiated Ca. = undifferentiated carcinoma.

 


View larger version (17K):

[in a new window]
 
FIGURE 2. Localization of primary tumors detected by 18F-FDG PET or by clinical follow-up in patients with UPT included in meta-analysis.

 


View larger version (14K):

[in a new window]
 
FIGURE 3. Estimated values and 95% CI of sensitivity (A) and specificity (B) in different types of studies (type I, type II, type A, and type B) and in pooled data (global). Global = pooled data; type I = 18F-FDG PET was performed when all diagnostic procedures performed did not detect primary tumor; type II = 18F-FDG PET was compared with CT or MRI in double-blind study after negative results for primary tumor detection with other diagnostic procedures; type A = whole-body 18F-FDG PET study was performed; type B = 18F-FDG PET study only included head-neck-thorax region.

 


View larger version (16K):

[in a new window]
 
FIGURE 4. ln OR in studies included in meta-analysis and in pooled data. Calculated values of ln OR and variance in all studies are shown as well as ln OR and 95% CI in pooled data.

 


View larger version (9K):

[in a new window]
 
FIGURE 5. Summary ROC curve for primary tumor detection with 18F-FDG PET in patients with UPT based on 15 studies included in meta-analysis.

 


View larger version (15K):

[in a new window]
 
FIGURE 6. Funnel plots of sensitivity and specificity. (A) Funnel plot of sensitivity shows no publication bias. (B) Funnel plot of specificity suggests presence of bias.

 





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2003 by the Society of Nuclear Medicine.